Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Cardiovascular, Cognitive and Subjective Effects of Atomoxetine in Combination With Intravenous Methamphetamine

NCT01019707 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01019707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01019707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Cardiovascular, Cognitive and Subjective Effects of Atomoxetine in Combination With Intravenous Methamphetamine
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2009
Completion date
December 31, 2010
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, methamphetamine dependence